Home › Compare › IRBS vs QYLD

IRBS vs QYLD: Dividend Comparison 2026

IRBS yields 3333333.33% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IRBS wins by $8.066963011092293e+41M in total portfolio value
10 years
IRBS
IRBS
● Live price
3333333.33%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.066963011092293e+41M
Annual income
$806,648,697,106,848,200,000,000,000,000,000,000,000,000,000,000.00
Full IRBS calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — IRBS vs QYLD

📍 IRBS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIRBSQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IRBS + QYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
IRBS pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IRBS
Annual income on $10K today (after 15% tax)
$283,333,333.33/yr
After 10yr DRIP, annual income (after tax)
$685,651,392,540,820,900,000,000,000,000,000,000,000,000,000,000.00/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, IRBS beats the other by $685,651,392,540,820,900,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IRBS + QYLD for your $10,000?

IRBS: 50%QYLD: 50%
100% QYLD50/50100% IRBS
Portfolio after 10yr
$4.033481505546146e+41M
Annual income
$403,324,348,553,424,100,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IRBS buys
0
QYLD buys
0
No recent congressional trades found for IRBS or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIRBSQYLD
Forward yield3333333.33% ✓11.92%
Annual dividend / share$2.00$2.04 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$8.066963011092293e+41M$25.4K ✓
Annual income after 10y$806,648,697,106,848,200,000,000,000,000,000,000,000,000,000,000.00 ✓$5,659.31
Total dividends collected$8.066931866681733e+41M$27.1K ✓
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: IRBS vs QYLD ($10,000, DRIP)

YearIRBS PortfolioIRBS Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$333,344,033$333,333,333.33$10,352$1,192.36+$333.33M → IRBS
2$10,384,906,003,142$10,384,549,325,025.96$10,830$1,347.57+$10384905.99M → IRBS
3$302,363,748,270,118,850$302,352,636,420,695,500.00$11,460$1,539.07+$302363748270.11M → IRBS
4$8,227,619,721,265,916,000,000$8,227,296,192,055,268,000,000.00$12,275$1,777.84+$8227619721265916.00M → IRBS
5$209,235,859,949,820,440,000,000,000$209,227,056,396,718,700,000,000,000.00$13,323$2,078.95+$209235859949820444672.00M → IRBS
6$4,972,966,428,923,558,700,000,000,000,000$4,972,742,546,553,412,000,000,000,000,000.00$14,667$2,463.34+$4.972966428923559e+24M → IRBS
7$110,461,904,714,538,420,000,000,000,000,000,000$110,456,583,640,459,500,000,000,000,000,000,000.00$16,396$2,960.57+$1.1046190471453842e+29M → IRBS
8$2,293,122,282,540,014,600,000,000,000,000,000,000,000$2,293,004,088,301,970,000,000,000,000,000,000,000,000.00$18,631$3,612.97+$2.2931222825400146e+33M → IRBS
9$44,489,721,851,484,010,000,000,000,000,000,000,000,000,000$44,487,268,210,641,690,000,000,000,000,000,000,000,000,000.00$21,548$4,482.15+$4.448972185148401e+37M → IRBS
10$806,696,301,109,229,300,000,000,000,000,000,000,000,000,000,000$806,648,697,106,848,200,000,000,000,000,000,000,000,000,000,000.00$25,398$5,659.31+$8.066963011092293e+41M → IRBS

IRBS vs QYLD: Complete Analysis 2026

IRBS — Stock

IR BioSciences Holdings, Inc. operates as a development stage biotechnology company in the United States. The company, through its subsidiary, ImmuneRegen BioSciences, Inc., engages in the research and development of therapies in the areas of pulmonary fibrosis, influenza infection, and radiation-induced Neutropenia. It is involved in the development of Homspera, and its derivates Radilex and Viprovex, for human stem cell stimulation, immune system stimulation and anti-infective activity, vaccine adjuvancy, and wound healing. IR BioSciences Holdings, Inc. was founded in 1999 and is headquartered in Scottsdale, Arizona.

Full IRBS Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this IRBS vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IRBS vs SCHDIRBS vs JEPIIRBS vs OIRBS vs KOIRBS vs MAINIRBS vs XYLDIRBS vs JEPQIRBS vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.